An overview of sexually transmitted infections among adolescents

Adolescent Medicine Clinics

Volumn 15, Issue 2, 2004, Pages 201-214

  Shafii, Taraneh ^a   Burstein, Gale R ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEHAVIOR; CHLAMYDIA; DISEASE PREDISPOSITION; ETHNOLOGY; GENDER; GONORRHEA; HERPES SIMPLEX VIRUS; HUMAN; INFECTION RISK; JUVENILE; MORBIDITY; PROPHYLAXIS; RACE; REVIEW; RISK FACTOR; SEXUALLY TRANSMITTED DISEASE; SOCIAL ASPECT; SYPHILIS; UNITED STATES; WART VIRUS;

ADOLESCENT; ADULT; AGE DISTRIBUTION; CHILD; FEMALE; HEALTHY PEOPLE PROGRAMS; HUMANS; MALE; RISK FACTORS; SEX DISTRIBUTION; SEXUALLY TRANSMITTED DISEASES; UNITED STATES;

EID: 3142648918     PISSN: 15473368     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.admecli.2004.02.001     Document Type: Review

References (33)

1. Alexander L.L., Cates J.R., Herndon N., Ratcliffe J.M. Sexually transmitted diseases in America: how many cases and at what cost? 1998;Kaiser Family Foundation, Menlo Park (CA)
2. Centers for Disease Control and Prevention Sexually transmitted diseases surveillance, 2002. 2003;US Department of Health and Human Services, Atlanta (GA)
3. Centers for Disease Control and Prevention Sexually transmitted diseases treatment guidelines 2002. MMWR Morb Mortal Wkly Rep. 51(RR-6):2002;32-36
4. United States Preventive Services Task Force Screening, chlamydia infection. Available at: http://www.ahcpr.gov/clinic/uspstf/uspschlm.htm. Accessed September 25, 2003
5. Burstein G.R., Zenilman J.M. Non-gonococcal urethritis: a new paradigm. Clin Infect Dis. Suppl 1:1999;S66-S73
6. Burstein G.R., Zenilman J.M., Gaydos C.A., Diener-West M., Howell M.R., Brathwaite W., et al. Predictors of repeat Chlamydia trachomatis infections diagnosed by DNA amplification testing among inner city females. Sex Transm Infect. 77(1):2001;26-32
7. Burstein G.R., Snyder M.H., Conley D., Boekeloo B.O., Quinn T.C., Zenilman J.M. Adolescent chlamydia testing practices and diagnosed infections in a large managed care organization. Sex Transm Dis. 28(8):2001;477-483
8. Centers for Disease Control and Prevention Sexually transmitted diseases surveillance report supplement: Gonococcal Isolate Surveillance Project (GISP) annual report-2002. October 2002;US Department of Health and Human Services, Atlanta (GA)
9. Centers for Disease Control and Prevention increases in fluoroquinolone-resistant Neisseria gonorrhoeae - Hawaii and California, 2001. MMWR Morb Mortal Wkly Rep. 51(46):2002;1041-1044
10. Burstein G.R., Berman S.M., Blumer J.L., Moran J.S. Ciprofloxacin for the treatment of uncomplicated gonorrhea infection in adolescents: does benefit outweigh risk? Clin Infect Dis. 35:2002;S191-S199
11. Centers for Disease Control and Prevention Sexually transmitted diseases treatment guidelines 2002. MMWR Morb Mortal Wkly Rep. 51(RR-6):2002;36-42
12. Ciesielski C.A. Sexually transmitted diseases in men who have sex with men: an epidemiologic review. Curr Infect Dis Rep. 5:2003;145-152
13. Corey L., Wald A. Genital herpes. Holmes K.K., Sparling P.F., Mardh P.A., Lemon S.M., Stamm W.E., Piot P., et al. Sexually transmitted diseases. 3rd edition:1999;285-312 McGraw-Hill, New York
14. Lafferty W.E., Downey L., Celum C., Wald A. Herpes simplex virus type 1 as a cause of genital herpes: impact on surveillance and prevention. J Infect Dis. 181(4):2000;1454-1457
15. Fleming D.T., McQuillan G.M., Johnson R.E., et al. Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med. 337(16):1997;1105-1111
16. th Biennial Congress of the International Society for Sexually Transmitted Diseases. 2003;58-59 The International Society for Sexually Transmitted Diseases, Ottawa (Canada)
17. Mertz G.J., Benedetti J., Ashley R., Selke S.A., Corey L. Risk factors for the sexual transmission of genital herpes. Ann Inter Med. 116(3):1992;197-202
18. Armstrong G.L., Schillinger J., Markowitz L., Nahmias A.J., Johnson R.E., McQuillan G.M., et al. Incidence of herpes simplex virus type 2 infection in the United States. Am J Epidemiol. 153(9):2001;912-920
19. De Villiers E.-M. Taxonomic classification of papillomaviruses. Papillomavirus Rep. 12:2001;57-63
20. Munoz N., Bosch F.X., de Sanjose S., Herrero R., Castellsague X., Shah K.V., et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 348(6):2003;518-527
21. Winer R.L., Lee S., Hughes J.P., Adam D.E., Kiviat N.B., Koutsky L.A. Genital papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol. 157(3):2003;218-226
22. Moscicki A.B., Shiboski S., Broering J., Powell K., Clayton L., Jay N., et al. The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women. J Pediatr. 132(2):1998;277-284
23. Stone K.M., Karem K.L., Sternberg M.R. Seroprevalence of human papillomavirus type 16 infection in the United States. J Infect Dis. 186(10):2002;1396-1402
24. Newacheck P.W., Brindis C.D., Cart C.U., Marchi K., Irwin C.E. Adolescent health insurance coverage: recent changes and access to care. Pediatrics. 104(2):1999;195-202
25. Ford C.A., Bearman P.S., Moody J. Foregone health care among adolescents. JAMA. 23:1999;2227-2234
26. Ford C.A., Best D., Miller W.C. Confidentiality and adolescents' willingness to consent to sexually transmitted disease testing. Arch Pediatr Adolesc Med. 155(9):2001;1072-1073
27. Boekeloo B.O., Snyder M.H., Bobbin M., Burstein G.R., Conley D., Quinn T.C., et al. Provider willingness to screen all sexually active adolescent for chlamydia. Sex Transm Infect. 78(5):2002;369-373
28. Westrom L., Eschenbach D. Pelvic inflammatory disease. Holmes K.K., Sparling P.F., Mardh P.A., Lemon S.M., Stamm W.E., Piot P., et al. Sexually transmitted diseases. 3rd edition:1999;783-810 McGraw-Hill, New York
29. Martin D.H., Bowie W.R. Urethritis in males. Holmes K.K., Sparling P.F., Mardh P.A., Lemon S.M., Stamm W.E., Piot P., et al. Sexually transmitted diseases. 3rd edition:1999;833-846 McGraw-Hill, New York
30. Laumann E.O., Youm Y. Racial/ethnic group differences in the prevalence of sexually transmitted diseases in the United States: a network explanation. Sex Transm Dis. 26(5):1999;250-261
31. Institute of Medicine The neglected health and economic impact of STDs. Eng T.R., Butler W.T. The hidden epidemic. 1997;28-68 National Academy Press, Washington (DC)
32. Centers for Disease Control and Prevention Healthy People 2010. Available at http://www.healthypeople.gov/Document/HTML/Volume2/25STDs.htm#_Toc489706322. Accessed September 17, 2003
33. Centers for Disease Control and Prevention: Youth risk surveillance - United States, 2001. MMWR CDC Surveill Summ. 51(SS-4):2002;15-17